Project Grant R43HD115467
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$385K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Bold Type LLC (J3SCK18AVKA1)
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Orlando, FL 32826, USA
Similar Awards
This $384,558 Project Grant award from the National Institutes of Health's (NIH) Child Health and Human Development Extramural Research program (CFDA 93.865) supports the development and evaluation of the "SenseWand" - a wireless pelvic floor diagnostic system (device and app) to assess pelvic floor muscle health using Electrical Impedance Myography (EIM). The recipient, Bold Type LLC, is a minority-owned, small disadvantaged business developing innovative medical devices and...
This Project Grant award of $384,923.00 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support the development of an innovative, girth-adjustable vaginal dilator with precise dilation monitoring. The primary goals are to improve patient pain management and adherence for the treatment of chronic pelvic floor disorders, which affect over 25 million women annually in the U.S. The key products to be...
The National Institute of Child Health and Human Development (NICHD) awarded Pelva Health Corporation a $328,496 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to develop a novel hydrogel film and applicator delivery system that helps mitigate pain experienced during sexual intercourse by women with gynecologic pain conditions, specifically vulvodynia and vestibulodynia. The goal is to create a non-pharmaceutical solution that reduces pressure on sensitive...
The National Institute of Child Health and Human Development (NICHD) awarded Madorra Inc., a woman-owned small business, a $1,514,498 SBIR Direct-to-Phase II Project Grant (CFDA 93.865) to develop an at-home, non-hormonal ultrasonic device for the treatment of vulvovaginal atrophy (VVA). VVA affects up to 90% of peri- and postmenopausal women, as well as many breast cancer survivors receiving estrogen-suppressing treatments. The project aims to 1) update the Madorra Therapy System design to...
The Project Grant award R43HD115425 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is supporting Theranova LLC, a veteran-owned medical device R&D company, to conduct a pilot clinical study evaluating the SOLESTIM neuromodulation system as a home-use treatment for dysmenorrhea (primary menstrual cramps). The $343,510 award will fund a 16-week,...
The University of North Carolina at Chapel Hill received a $100,000 Project Grant award from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a digital therapeutic device and mobile application for patients with high-tone pelvic floor disorders. The award will support the creation of an interactive pelvic wand and accompanying smartphone app to enable patients to conduct targeted pelvic floor muscle physical therapy...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $299,518 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to V-Flow Medical Inc. to develop a novel diagnostic catheter and modular stent system to treat pelvic venous insufficiency (PVI), a primary cause of chronic pelvic pain (CPP) in women. The project will utilize an ovine model to evaluate the safety and efficacy of V-Flow's catheter and stent system in improving clinical outcomes...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,516,765 to the University of California, Los Angeles (UCLA) to develop and validate an innovative near-infrared spectroscopy (NIRS) technology for the quantitative assessment of pelvic floor muscle function in patients with myofascial pelvic pain (MPP). The research aims to establish NIRS as an effective, non-invasive,...
This Project Grant award of $6,154,752, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research aimed at understanding how menstrual pain and bladder hypersensitivity interact to promote chronic pelvic pain (CPP). The 3-year study, starting on September 17, 2024, will be conducted by Endeavor Health Clinical Operations, a non-profit research institute at Evanston Hospital. The project will...
The University of Health Sciences and Pharmacy in St. Louis received a $474,946 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), to develop a novel, non-hormonal, female-initiated contraceptive device. The project aims to create a dual-compartment vaginal device that enables women to administer a contraceptive smart fiber mat and a...